Most everyone here has been saying that for a decade, some longer. Always soon for RDGL, always soon. MK flushes a decade down toilet, but it's always soon for RDGL. Doesn't matter now anyway. The window of opportunity for a mega buyout has long passed. The tech is public domain now. Same can be said of their competitors. Injectable Y90 gel is a generic tech now, so even 1st to market product has to priced to discourage competitive entry.
Market Data 
Markets 
AI
